Basel Medical Group Ltd (BMGL) Key Metrics
BMGL key metrics, FY2024–FY2025
Fiscal year ended June 30, 2025 · Singapore dollarsBMGL returns How much profit the business earns on the capital it uses.
BMGL financial health Debt, liquidity and how easily interest is covered.
BMGL efficiency & capital use Working capital cycle and where the cash goes.
BMGL returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
BMGL debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
BMGL key metrics in Singapore dollars
FY2024–FY2025| FY2025 | FY2024 | |
|---|---|---|
| Returns & profitability | ||
| Return on equity (ROE) | −194.6% | 27.4% |
| Return on invested capital (ROIC) | −22.7% | 19.1% |
| Return on assets (ROA) | −72.9% | 12.7% |
| Return on tangible assets | −71.7% | 12.7% |
| Free cash flow margin | −38.9% | 24.9% |
| Income quality (OCF / net income) | — | 1.21 |
| Financial health | ||
| Total debt | S$3.4M | S$4.3M |
| Cash & short-term investments | S$3.0M | S$2.0M |
| Net debt | S$440,393 | S$2.3M |
| Debt / equity | 0.70 | 0.57 |
| Debt / assets | 0.20 | 0.26 |
| Net debt / EBITDA | — | 0.75 |
| Current ratio | 1.23 | 2.26 |
| Quick ratio | 1.19 | 2.25 |
| Interest coverage | -10.7 | 12.5 |
| Working capital | S$2.4M | S$9.0M |
| Invested capital | S$5.3M | S$9.9M |
| Tangible asset value | S$4.9M | S$7.6M |
| Net current asset value | S$1.1M | S$7.4M |
| Capital allocation | ||
| Capex / revenue | 0.5% | 0.1% |
| Capex / operating cash flow | — | 0.3% |
| Capex / depreciation | 0.05 | 0.01 |
| SG&A / revenue | 57.8% | 36.2% |
| Efficiency | ||
| Days sales outstanding | 240.8 | 451.9 |
| Days of inventory on hand | 32.4 | 11.7 |
| Days payables outstanding | 211.4 | 134.6 |
| Cash conversion cycle (days) | 61.8 | 329.0 |
| Receivables turnover | 1.52 | 0.81 |
| Payables turnover | 1.73 | 2.71 |
| Inventory turnover | 11.27 | 31.21 |
| Asset turnover | 0.68 | 0.62 |
| Average receivables | S$7.5M | S$12.4M |
| Average payables | S$1.5M | S$829,324 |
| Average inventory | S$224,160 | S$72,030 |
| Intangibles / total assets | 0.0% | 0.0% |
Computed from BMGL's annual financial statements (latest annual report filed November 18, 2025) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in Singapore dollars; data from EODHD. Averages use the opening and closing balance of each year.
BMGL valuation and financial ratios
Basel Medical earned a return on equity of −194.6% and a return on invested capital of −22.7% in fiscal 2025. It ended the year with S$3.4 million of debt and S$3.0 million in cash and short-term investments, net debt of S$0.4 million.
See the BMGL income statement, the BMGL chart for price history, or the BMGL stock overview for the latest quote and news.
BMGL key metrics FAQ
What is Basel Medical's return on equity?
Basel Medical's return on equity (ROE) was −194.6% in fiscal 2025: net income of -S$12.1 million on average shareholders' equity of S$6.2 million.
What is Basel Medical's ROIC?
Basel Medical's return on invested capital was −22.7% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Basel Medical have?
Basel Medical had total debt of S$3.4 million at the end of fiscal 2025, a debt-to-equity ratio of 0.70.
What is Basel Medical's current ratio?
Basel Medical's current ratio was 1.23 at the end of fiscal 2025: current assets were 1.23 times current liabilities.